ALK and non-small cell lung carcinoma: In NSCLC, ALK gene fusions have a relatively high incidence rate, with echinoderm microtubule-associated protein-like 4 (EML4) as a predominant fusion partner; thus, it is reasonable to use RT-PCR and FISH as routine screening methods for genetic diagnosis.